Pregnancy in rheumatology patients exposed to anti-tumor necrosis factor(TNF)-alfa therapy
ROUX CH; BROCQ O, BREUIL V, ALBERT C, EULLER-ZIEGLER L. Pregnancy in rheumatology patients exposed to anti-tumor necrosis factor(TNF)-alfa therapy. Rheumatology (Oxford) 2007; 46: 695-698.
Efficacy and safety of etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy
MICHELOUD D, NUÑO L, RODRÍGUEZ- MAHOU M, SÁNCHEZ-RAMÓN S, ORTEGA MC, AQUARÓN A et al. Efficacy and safety of etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy. Lupus 2006; 15: 881-885.
Pregnancy in rheumatology patients exposed to antitumour necrosis factor (TNF)-alfa therapy
ROSNER I, HADDAD A, BOULMAN N, FELD J, AVSHOVICH N, SLOBODIN G et al. Pregnancy in rheumatology patients exposed to antitumour necrosis factor (TNF)-alfa therapy. Rheumatology 2007; 46: 1508-1509.